The store will not work correctly when cookies are disabled.
US8618286, 8
ID: ALA3675236
PubChem CID: 44546584
Max Phase: Preclinical
Molecular Formula: C16H20N4S2
Molecular Weight: 332.50
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CNCCN1CCSc2cc(/N=C(\N)c3cccs3)ccc21
Standard InChI: InChI=1S/C16H20N4S2/c1-18-6-7-20-8-10-22-15-11-12(4-5-13(15)20)19-16(17)14-3-2-9-21-14/h2-5,9,11,18H,6-8,10H2,1H3,(H2,17,19)
Standard InChI Key: RCCUTHJBDBDXNI-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
6.2387 -0.8917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2003 -1.4932 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8990 -0.7455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6003 -1.4977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 -3.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -3.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -3.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8963 -3.7531 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8941 -5.2539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8539 -5.8521 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.1923 -6.0070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3302 -7.4879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.7974 -7.7998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.5474 -6.5007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5437 -5.3860 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 5 1 0
14 9 1 0
11 15 1 0
15 16 2 0
16 17 1 0
16 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 18 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 332.50 | Molecular Weight (Monoisotopic): 332.1129 | AlogP: 2.92 | #Rotatable Bonds: 5 |
Polar Surface Area: 53.65 | Molecular Species: BASE | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.66 | CX LogP: 2.80 | CX LogD: -0.66 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.65 | Np Likeness Score: -1.68 |
References
1. (2013) Benzoxazines, benzothiazines, and related compounds having NOS inhibitory activity, |